Search hospitals > Maine > Scarborough
New England Cancer Specialists
Claim this profileScarborough, Maine 04074
Global Leader in Breast Cancer
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Tumors
54 reported clinical trials
2 medical researchers
Summary
New England Cancer Specialists is a medical facility located in Scarborough, Maine. This center is recognized for care of Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Cancer, Tumors and other specialties. New England Cancer Specialists is involved with conducting 54 clinical trials across 48 conditions. There are 2 research doctors associated with this hospital, such as Chiara Battelli, MD and John P Winters, III, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
Stage IV
HER2 negative
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
Top PIs
Chiara Battelli, MDNew England Cancer Specialists1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
9 reported clinical trials
23 drugs studied
John P Winters, III, MDNew England Cancer Specialists2 years of reported clinical research
Studies Lymphoma
Studies Chronic Lymphocytic Leukemia
1 reported clinical trial
2 drugs studied
Clinical Trials running at New England Cancer Specialists
Breast Cancer
Non-Small Cell Lung Cancer
Lymphoma
Chronic Lymphocytic Leukemia
Chronic B-Cell Leukemia
Lung Cancer
Cancer
Lymphoid Leukemia
Leukemia
Solid Tumors
Giredestrant + Everolimus
for Advanced or Metastatic Breast Cancer
This trial is testing if a combination of giredestrant and everolimus works better than other hormone treatments plus everolimus in patients with advanced breast cancer who have already tried other treatments. The drugs work by blocking estrogen receptors and a growth pathway in cancer cells. Everolimus has been shown to improve outcomes in breast cancer patients when combined with hormonal treatments.
Recruiting2 awards Phase 37 criteria
Giredestrant vs. Fulvestrant
for Advanced Breast Cancer
This trial is testing two drug combinations to treat a specific type of advanced breast cancer that no longer responds to standard hormone treatments. The goal is to see which combination works better by stopping the cancer cells from growing.
Recruiting2 awards Phase 38 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at New England Cancer Specialists?
New England Cancer Specialists is a medical facility located in Scarborough, Maine. This center is recognized for care of Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Cancer, Tumors and other specialties. New England Cancer Specialists is involved with conducting 54 clinical trials across 48 conditions. There are 2 research doctors associated with this hospital, such as Chiara Battelli, MD and John P Winters, III, MD.